In response to the arguments put forward by Dryden (2023), this paper discusses the disproportionate toll of the COVID-19 pandemic on racially marginalized communities - particularly, Black healthcare workers. There were numerous reports in the media that Black people were being treated poorly by healthcare providers and that Black healthcare workers felt poorly protected compared to their white counterparts. This paper argues that the National Health Service has been maintained through a system of racial capitalism. The author proposes that to address racial health inequity a more in-depth understanding of our shared colonial history is required.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.12927/hcpap.2023.27193 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characteristics and management of eosinophilic esophagitis in Australasian children: a decade of experience.
Intern Med J
December 2024
Department of Paediatrics, Fiona Stanley Hospital, Perth, Western Australia, Australia.
Background: The frequency of EoE has been increasing in Northern Hemisphere cohorts, yet there is a scarcity of data in our region. Regional climatic factors, and lifestyle habits may influence the presentation of EoE, and appropriate management is crucial to prevent complications. WIth this is mind we undertook the first comprehensive multisite study of EoE in Australasian children.
View Article and Find Full Text PDFAccess to Pediatric Bed Capacity According to Social Determinants of Health: All Beds Are Not Created Equal.
J Pediatr
December 2024
Department of Pediatrics, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA; Department of Cardiology, Boston Children's Hospital, Boston, MA, USA; Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Sandra L. Fenwick Institute for Pediatric Health Equity and Inclusion, Boston Children's Hospital, Boston, MA, USA. Electronic address:
Objective: To study pediatric inpatient hospital capacity and resources, characterizing differences according to social determinants of health (SDoH) using market share techniques.
Study Design: This cross-sectional study uses non-elective inpatient discharges (≥1 month to ≤19 years) from Healthcare Cost and Utilization Project and American Hospital Association surveys to derive hospital capacity and resources/capability. We include US hospitals with ≥1 pediatric bed and ≥1 pediatric discharge and calculate per bed capital, expenditure, and staffing, transfer rates, payer-mix, and adjusted central line-associated blood stream infection (CLABSI) rate.
Severe maternal morbidity and potential disparities by race and rurality among VA-covered births, 2010 to 2020.
Am J Obstet Gynecol
December 2024
VA Health Economics Resource Center (HERC), US Department of Veterans Affairs, VA Palo Alto Health Care System, Menlo Park, CA, USA; VA HSR&D Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, Palo Alto, CA, USA; Division of Neonatology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Food assistance use barriers, facilitators, and recommendations: insights from a qualitative study of racially and ethnically diverse parents.
J Nutr Sci
December 2024
Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, MN, USA.
The objective of this study was to explore barriers and facilitators to utilising a range of food assistance resources as reported by parents living with or at risk for food insecurity (FI), as well as parents' recommendations for improving utilisation of these resources. Qualitative data from semi-structured interviews about parents' perspectives on interventions to address FI were analysed using a hybrid deductive/inductive thematic approach. Parents were drawn from the larger longitudinal cohort study ( = 1,307), which was recruited from primary care clinics in Minnesota.
View Article and Find Full Text PDFRacial differences in real-world outcomes of first-line therapies for advanced renal cell carcinoma.
Oncologist
December 2024
Global Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, NJ 08648, United States.
Background: Given the historical underrepresentation of racial minorities in clinical trials, little is known about racial differences in outcomes of first-line therapies for advanced renal cell carcinoma (aRCC). This study described patient characteristics and clinical outcomes of first-line therapies for aRCC, including nivolumab + ipilimumab, pembrolizumab + axitinib, and tyrosine kinase inhibitors, by race in the real-world setting.
Methods: We conducted a retrospective medical chart review of patients with intermediate/poor-risk clear-cell aRCC.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!